Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia

被引：3
|
作者：
Beauclair, L
Lam, A
McCormick, J
Luong, D
Camacho, F
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67769-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A202 / A203
页数：2
相关论文
共 50 条
  • [31] Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with 291 schizophrenia
    De Marinis, T.
    Saleem, P. T.
    Glue, P.
    Arnoldussen, W. J.
    Teijeirol, R.
    Lex, A.
    Latif, M. A.
    Medori, R.
    PHARMACOPSYCHIATRY, 2007, 40 (06) : 257 - 263
  • [32] Risperidone long-acting injectable in patients with a new diagnosis of psychosis
    Parellada, E
    Chrzanowski, W
    Andrezina, R
    Milanova, V
    Glue, P
    Medori, R
    Masiak, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S75 - S76
  • [33] Effect of long-acting injectable risperidone on clinical outcomes in recently diagnosed stable schizophrenia patients
    Ibach, B.
    Bossie, C.
    Turkoz, I.
    Haskins, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 157 - 157
  • [34] Changing from polytherapy to risperidone long-acting injectable improved symptom control in schizophrenia patients
    Tzanakaki, M
    Kontis, K
    Andrezina, R
    Medori, R
    Peretti, CS
    EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S79
  • [35] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Rosa, Fernanda
    Schreiner, Andreas
    Thomas, Pierre
    Sherif, Tarek
    CLINICAL DRUG INVESTIGATION, 2012, 32 (04) : 267 - 279
  • [36] Attitudes toward long-acting injectable risperidone
    Han, C.
    Lee, B. H.
    Kim, Y. K.
    Choi, J. Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S266 - S266
  • [37] Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable
    Duncan, Erica J.
    Woolson, Sandra L.
    Hamer, Robert M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (05) : 283 - 290
  • [38] Extrapyramidal syndrome and long-acting injectable risperidone
    Hale, AS
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (04): : 756 - 757
  • [39] Long-acting injectable risperidone: Efficacy and safety
    Kane, JM
    Eerdekens, M
    Keith, SJ
    Lesem, M
    Karcher, K
    Lindenmayer, JP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
  • [40] Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable
    Fernanda Rosa
    Andreas Schreiner
    Pierre Thomas
    Tarek Sherif
    Clinical Drug Investigation, 2012, 32 : 267 - 279
12345